Elevosteo 250mcg Injection
Marketer
Xyata Life Sciences Pvt Ltd
Salt Composition
Teriparatide (250mcg)
Overview Elevosteo 250mcg Injection
For severe osteoporosis and heightened fracture risk in men and postmenopausal women, Forteo (250mcg) injection offers a synthetic parathyroid hormone. This medication promotes bone growth, increasing bone density and reducing spinal fracture probability. Administered subcutaneously or by a healthcare provider, Forteo requires consistent daily self-injection for optimal results. Treatment typically lasts up to two years, though your physician will determine the appropriate duration. Refrigerate between 2°C and 8°C. Common side effects may include arthralgia, injection site inflammation (pain, swelling, redness), and lower extremity spasms. Report persistent or bothersome symptoms to your doctor. Prior to commencing therapy, disclose any kidney issues (including stones) as Forteo can elevate blood or urine calcium levels. Pregnant or nursing individuals should seek medical counsel before use. Your doctor might order bone density scans to track treatment effectiveness.
Uses of Elevosteo 250mcg Injection
Bone fragility
Major Benefits of Elevosteo 250mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Elevosteo 250mcg Injection:
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Nausea
- Leg cramps
How to use Elevosteo 250mcg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Elevosteo 250mcg Injection works:
A synthetic version of the naturally occurring parathyroid hormone (PTH), Elevosteo 250mcg Injection stimulates osteoblast activity and proliferation, leading to enhanced bone strength and a reduced fracture risk.
SAFETY ADVICE
AlcoholCAUTION
Use of Elevosteo 250mcg Injection with alcohol requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Elevosteo 250mcg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible hazards prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Elevosteo 250mcg Injection with breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Administering Elevosteo 250mcg Injection might cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with impaired kidney function should use Elevosteo 250mcg Injection cautiously, potentially requiring dosage modification. A physician's consultation is advised. Elevosteo 250mcg Injection is contraindicated in patients exhibiting severely compromised kidney function.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Elevosteo 250mcg Injection to individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Elevosteo 250mcg Injection :
Should you forget a dose of Elevosteo 250mcg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Elevosteo 250mcg Injection
| Label | Value |
|---|---|
| Chemical Type | Parathyroid Hormone-related Medications |
| Developing Habits | No. |
| Type of Therapy | Endocrine Signals |
3,018 People bought this recently